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permits non-commercial use, distribution, and reproduction in any medium, provided the original author and source are credited.SUMMARYVery small embryonic-like stem cells (VSELs) isolated from bonemarrow (BM) have been reported to be pluripotent. Given their nonem-
bryonic source, they could replace blastocyst-derived embryonic stem cells in research andmedicine. However, theirmultiple-germ-layer
potential has been incompletely studied. Here, we show that we cannot find VSELs in mouse BM with any of the reported stem cell po-
tentials, specifically for hematopoiesis.We found that: (1)most eventswithin the ‘‘VSEL’’ flow-cytometry gate had little DNAand the cells
corresponding to these events (2) could not form spheres, (3) did not express Oct4, and (4) could not differentiate into blood cells. These
results provide a failure to confirm the existence of pluripotent VSELs.INTRODUCTION
During normal development, pluripotent cells from the in-
ner cell mass give rise to several types of tissue-committed
stem cells (TSCs), restricted in their differentiation poten-
tial. TSCs can self-renew and produce downstream progen-
itors andmature cells throughout life. It remains controver-
sial (Wagers et al., 2002; Wagers and Weissman, 2004)
whether some pluripotent cells self-renew as pluripotent
stem cells (PSCs) and persist after birth (Beltrami et al.,
2007; Check, 2007; Jiang et al., 2002; Ko¨gler et al., 2004;
Krause et al., 2001; Serafini et al., 2007).
One group has recently identified bone marrow (BM)-
residing very small embryonic-like stem cells (VSELs) in
both human and mouse as a putative nonembryonic
source for PSCs (Druka1a et al., 2012; Kucia et al.,
2006b; Wojakowski et al., 2009; Zuba-Surma et al.,
2011). Mouse VSELs have been characterized to: (1) be
very small (3–5 mm), (2) have a CD45Lineage(Lin)
SCA-1+ phenotype, (3) express pluripotent marker genes
(e.g., Oct4, Nanog), and (4) when cultured on the
myoblast C2C12 cell line, form embryoid body-like
spheres and then differentiate into multi-germ-layer cells.
Moreover, these cells were reported to be directly obtain-
able from BM or mobilized peripheral blood without cul-
ture. Thus, their pluripotency should be reproducible in
independent laboratories, a requirement for a scientific
finding to be generally accepted (Jasny et al., 2011). How-
ever, recent studies have shown the lack of stem cell char-
acteristics in VSELs isolated from mouse (Szade et al.,
2013) or human cord blood (CB) (Danova-Alt et al.,198 Stem Cell Reports j Vol. 1 j 198–208 j August 6, 2013 j ª2013 The Auth2012), while another study confirmed the existence of
mouse VSELs and their ability to give rise to lung cells
(Kassmer et al., 2013).
We sought to recapitulate the previous findings on
relating to mouse VSELs, focusing on the DNA content of
the small-sized fraction and on its hematopoietic lineage
potential. We discovered an anomaly in separating cells
by forward scatter (FSC) using different types of cell sorters
and, more significantly, could not find PSCs within the
VSEL fraction of mouse BM.RESULTS
Identifying and Characterizing Candidate VSEL Cells
We sought to identify VSELs from mouse BM by using
commonly reported VSEL characteristics (Kucia et al.,
2006a; Ratajczak et al., 2011; Zuba-Surma et al., 2008).
We fractionated BM samples using fluorescence-activated
cell sorting (FACS). Dead cells and debris were excluded
as Ratajczak and colleagues previously reported (Zuba-
Surma et al., 2008). To minimize the risk of missing candi-
date cells, SCA-1+ cells (including SCA-1lo) beyond the
threshold defined by the fluorescence minus one (FMO)
method (Herzenberg et al., 2006) were included, and only
the obvious Lin+ cells were excluded from the Lin fraction
(which included Linlo cells). Consequently, the LinSCA-1+
gate was more inclusive than that described elsewhere for
VSELs and included all cells reported to be in the VSEL frac-
tion (Kucia et al., 2006a; Ratajczak et al., 2008a, 2011).
LinSCA-1+ events were subdivided into three fractionsors
Figure 1. Adult Mouse Bone Marrow CD45LinSCA-1+ Cells Enriched in the FSClo Region Contain Little DNA
(A) FACS plots of BM cells from wild-type mice. The initial gate (left middle) was based on defined-size microspheres (left upper) and
expected to include both HSCs and VSELs. After excluding dead cells (left bottom), we focused on the LinSCA-1+ fraction (center upper),
subdividing these into FMO-defined CD45 (dashed line in center middle), CD45int, and CD45hi fractions (center bottom). The frequency of
FSClo (<10 mm microspheres) and FSChi (>10 mm microspheres) cells in each subfraction is indicated (right panels).
(B) Frequency of FSClo (left) or FSChi (right) cells among the CD45, CD45int, and CD45hi subfractions of LinSCA-1+ events. The mean ± SD
of data from 22 independent experiments are shown.
(C) Analysis of DNA content by SYTO16 staining. The threshold of high SYTO16 positivity was determined to include 99% of unfractionated
BM cells (upper right). The vertical line in the lower plots indicates the position of 10 mm microspheres.
See also Tables S1 and S2.
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online).
We used the FSC intensity of 10 mm microspheres to
define the cutoff point between FSClo and FSChi events. As
previously reported (Zuba-Surma et al., 2008), the CD45
fraction contained many more FSClo cells than FSChi cells.
Conversely, the CD45hi fraction contained many more
FSChi cells than FSClo cells (Figure 1B; Tables S1 and S2).
FSClo events could include erythrocytes, vesicles, or cell
fragments and/or debris. Since the original group has stated
several times that VSELs are diploid (Kucia et al., 2008; Ra-
tajczak et al., 2007, 2008b), we analyzed DNA content of
FSClo events using SYTO16, a cell-membrane permeable
DNA dye. We found that SYTO16hi events, representative
of diploid cells, were present in about 98% of the CD45hiStem CLinSCA-1+ fraction but only 10% of the CD45/int
LinSCA-1+ fraction (Figure 1C). The remaining events in
the CD45/intLinSCA-1+ gate showed much lower inten-
sity for SYTO16, indicating that these were likely to be
cell fragments and not diploid cells. Furthermore, most of
the CD45/intLinSCA-1+SYTO16hi cells were in the FSChi
gate (Figure 1C). This indicated that our VSEL candidates
were the relatively larger cells in the population analyzed,
unlike the VSELs described in previous reports (Kucia
et al., 2006a; Ratajczak et al., 2011; Wojakowski et al.,
2009; Zuba-Surma et al., 2008, 2009).
Flow Cytometry in Assessing Size of Candidate VSELs
We hypothesized that this discrepancy was due to the type
of flow cytometer used: Ratajczak et al. (2011)mainly used aell Reports j Vol. 1 j 198–208 j August 6, 2013 j ª2013 The Authors 199
Figure 2. Evaluation of Cell Size by Different Cell Sorters
(A) Defined-size microspheres (upper) and whole BM cells (lower) were analyzed by FACSAria (left) and MoFlo (right). Dashed lines indicate
the FSC of 10 mm microspheres. The positions of lymphocytes (Lym) and granulocytes (Gra) are indicated in the lower panels.
(B) On a FACSAria, BM cells were sorted by expected size (2–6, 6–10, and >10 mm) based on their FSC relative to microspheres (upper) and
then reanalyzed on the same FACSAria (middle) and on a MoFlo (lower). Vertical lines indicate the positions of 2, 6, and 10 mm micro-
spheres on each machine.
(C) FACS plots of diploid (SYTO16hi) CD45/intLinSCA-1+ cells (candidate VSELs; left) and CD45hiLinSCA-1+ cells (HSCs; right) analyzed by
FACSAria (upper) or MoFlo (lower). Vertical lines indicate the position of 10 mm microspheres in each sorter, and horizontal lines indicate
the threshold of SYTO16 positivity.
(D) Comparison of the sizes of candidate VSELs (n = 34) and HSCs (n = 100) determined with an image flow cytometer. Each dot represents a
cell, and each line with error bars represents the mean ± SD.
See also Figure S1.
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butwe used a FACSAria (BDBiosciences). Thus,we analyzed
the same BM sample on a FACSAria and MoFlo. Based on
the FSC intensity of unfractionated BM, 10 mm micro-
spheres were positioned to the left of lymphocytes on the
FACSAria but in between lymphocytes and granulocytes
on the MoFlo (Figure 2A). Using the FACSAria and the
MoFlo,we sorted the BMsample into three subpopulations,
basedon the FSC intensity of defined-sizemicrospheres.We
then reanalyzed each of these subpopulations on both the
FACSAria and MoFlo. Critically, a given population of cells200 Stem Cell Reports j Vol. 1 j 198–208 j August 6, 2013 j ª2013 The Authseemed smaller (based onmicrosphere reference FSC inten-
sities) on the MoFlo than on the FACSAria (Figures 2B and
S1A). However, fluorescence intensity of the cell-to-cell
comparison did not differ between the sorters (Figure S1B).
Finally, we evaluated the FSC of candidate VSELs and he-
matopoietic stem/progenitor cells on FACSAria andMoFlo.
Notably, more than 70% of candidate VSELs were detected
in the FSChi gate on FACSAria, whereas >80% of themwere
in the FSClo gate on MoFlo (Figure 2C).
To address the concern that flow cytometer FSC based on
microspheres is not a reliable indicator of absolute size, weors
Figure 3. No Evidence for the Pluripotency of CD45/intLinSCA-1+ Cells
(A) Real-time RT-PCR analysis of Oct4 expression in subfractions of LinSCA-1+ cells and in ESCs (BM cells were prepared as a pool of four
mice and then sorted in quadruplicate and subjected to RT-PCR; the data are shown as mean ± SD). ND, not detected.
(B) Representative images of 8 day progeny of FACS-purified LinSCA-1+ populations from Actin-EGFP mice. Cells were cocultured with
C2C12 cells in DMEM supplemented with 2% FCS. Scale bar, 50 mm.
(C) The total number of GFP+ cells detected by FACS analysis at day 8 coculture of either 1,000 CD45/intLinSCA-1+ events or 1,000
CD45hiLinSCA-1+ events (n = 11 for each from three independent experiments); the red line indicates the mean.
(D) FACS analysis of Oct4-derived EGFP expression on culture day 8. On day 0, the following were plated on C2C12 cells: no cells (far left
column) or BM cells from Oct4-EGFP or Actin-EGFP mice, sorted by the indicated phenotypes. Data shown are representative of three
independent experiments.
See also Figure S2 and Table S3.
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(FlowSight, Amnis). We captured 2 3 106 BM cells and
identified 34 events having the immunophenotype corre-
sponding to the candidate VSELs (Figure S1C). Their
mean diameter was nonsignificantly smaller than that of
a randomly selected population of 100 CD45hiLinSCA-
1+SYTO16hi events (7.06 versus 7.51 mm; p = 0.82;
Figure 2D). However, only the candidate VSEL fraction con-
tained few very small-sized (<5 mm) particles, as previously
shown in fetal liver-resident VSELs (Zuba-Surma et al.,
2009).
Assessment of VSEL Candidates for Indicators of
Pluripotency
To determine whether the CD45/intLinSCA-1+ fraction
contained any pluripotent cells, we compared Oct4 expres-Stem Csion levels among freshly purified CD45/intLinSCA-1+
and CD45hiLinSCA-1+ cells and a mouse embryonic
stem cell (ESC) line using quantitative RT-PCR with four
different primer pairs. We could not detect Oct4 expression
in CD45/intLinSCA-1+ (both SYTO16hi and SYTO16lo)
cells at all (Figure 3A). These results contrast with previous
reports (Kassmer et al., 2013; Kucia et al., 2006a; Ratajczak
et al., 2011; Shin et al., 2010).
Next, we performed a sphere-forming assay using a
mouse myoblastic C2C12 cell line (Kucia et al., 2008;
Shin et al., 2010). The C2C12 cell line is known to initiate
its own differentiation and form muscle tubules when
cultured in low serum concentrations (Yaffe and Saxel,
1977).We observed that, when cultured alone, C2C12 cells
aggregated spontaneously and sometimes formed sphere-
like structures (Figure S2A). Therefore, to distinguishell Reports j Vol. 1 j 198–208 j August 6, 2013 j ª2013 The Authors 201
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spontaneous aggregation of C2C12 cells, we isolated candi-
date VSELs from Actin-EGFP transgenic mice and cocul-
tured them with C2C12 cells. Some GFP+ cells proliferated
and formed small clusters (Figure 3B) but never the spheres
described in previous reports (Kucia et al., 2008; Shin et al.,
2010). Eight-day progeny was harvested and analyzed for
the absolute number of GFP+ cells by flow cytometry. The
mean number of GFP+ cells initiated from the CD45/int
LinSCA-1+ fraction was significantly lower than that
from the CD45hiLinSCA-1+ fraction: 27.2 versus 1764;
p = 0.0002, respectively (Figure 3C). We repeated this assay
with BM samples harvested from Oct4-EGFP transgenic
mice. However, we could not detect any GFP+ cells in day
8 cultures of the following originally plated cells: 1,000
CD45/intLinSCA-1+, 5,000 CD45hiLinSCA-1+, or 105
unfractionated BM cells (Figure 3D). The addition of leuke-
mia inhibitory factor and/or usage of mouse embryonic
fibroblasts instead of C2C12 cells did not affect the results
(data not shown).
Grown GFP+ cells from both CD45/intLinSCA-1+ and
CD45hiLinSCA-1+ fractions had similar morphologies:
an unlobulated nucleus andmany vacuoles in voluminous
cytoplasm, suggestive of macrophages (Figure S2B).
Furthermore, flow cytometry analysis confirmed these
GFP+ cells expressed high levels of CD45 (a hematopoietic
lineage marker) and CD11b (a macrophage marker; Fig-
ure S2C). Since C2C12 cells are reported to secrete macro-
phage-colony stimulating factor (M-CSF) into the culture
supernatant (Ghosh-Choudhury et al., 2006), it is possible
that they may induce macrophage differentiation to either
CD45/intLinSCA-1+ or CD45hiLinSCA-1+ cells via
M-CSF signaling.
To demonstrate the pluripotency of a particular cell,
clonal expansion without differentiation from a single
cell in vitro is an indispensable step. However, the
C2C12 cells did not work to induce this expansion in
candidate VSELs. Therefore, we sought another way to
demonstrate that CD45/intLinSCA-1+ cells are pluripo-
tent or at least could even generate any tissue-specific line-
age. We focused on testing hematopoietic potential
because (1) a previous report showed that transplantation
of cultured VSELs could reconstitute the hematopoietic
system (Ratajczak et al., 2011) and (2) methods of purifica-
tion and functional analyses of hematopoietic stem cells
(HSCs) have been established (Spangrude et al., 1988;
Uchida and Weissman, 1992). If hematopoietic potential
cannot be recapitulated, the cells in the VSEL fraction
must not be pluripotent.
Freshly isolated CD45LinSCA-1+ BM cells (including
both FSClo and FSChi) did not proliferate under hematopoi-
etic culture conditions (Figures S3A and S3B). A recent
report indicated that 5-day coculture with the OP9 stromal202 Stem Cell Reports j Vol. 1 j 198–208 j August 6, 2013 j ª2013 The Authcell line (i.e., OP9 priming) is critical for VSELs to be desig-
nated for a hematopoietic lineage (Ratajczak et al., 2011).
In accordance with previous reports (Nakano et al., 1994;
Seiler et al., 2011), we found that, when cocultured with
OP9 cells, an ESC line was capable of hematopoietic differ-
entiation (data not shown); this served as a positive con-
trol. However, CD45LinSCA-1+ cells could not generate
hematopoietic colonies in the methylcellulose assay, even
after OP9 priming (Figures 4A and 4B). The addition of
various hematopoietic cytokines during the OP9 priming
did not affect the results (data not shown). Furthermore,
CD45LinSCA-1+ cells failed to produce any hematopoi-
etic cells under the following additional conditions:
(1) serial plating (Ratajczak et al., 2011); (2) including SY-
TOX-Blue positive fraction; (3) using only the SYTO16hi
cells obtained from ten mice; (4) using cells from H2K-
BCL-2 transgenic mice (Domen et al., 1998); or (5) using
cells sorted on a MoFlo machine (data not shown). These
observations indicate that the FMO-defined
CD45LinSCA-1+ fraction, at least in vitro, lacks hemato-
poietic potential, as recently described both for mouse
VSELs (Szade et al., 2013) and their human counterparts
(Danova-Alt et al., 2012).
CD45intLinSCA-1+FSChi cells with Limited
Hematopoietic Potential Originated from HSCs
Within the remaining CD45hiLinSCA-1+ fraction, 38.0%
of CD45hiLinSCA-1+FSChi cells but no CD45hiLinSCA-1+
FSClo cells formed hematopoietic colonies. Also, 1.86% of
CD45intLinSCA-1+FSChi cells formed hematopoietic col-
onies (Figure 4B). Many colonies from the CD45int
LinSCA-1+FSChi fraction contained fewer cells than those
from theCD45hiLinSCA-1+FSChi fraction, and their differ-
entiation potential was restricted to nonerythroid cells and
tended to skew to the monocyte/macrophage lineage (Fig-
ures 4C and S3C). In addition, when compared to CD45hi
LinSCA-1+FSChi cells, CD45intLinSCA-1+FSChi cells
showed a more indented nucleus, lower levels of SCA-1,
and higher levels of Lin and side scatter (Figures S3D and
S3E). These findings suggest that the CD45intLinSCA-1+
FSChi cells are at a lineage stage downstream of the CD45hi
LinSCA-1+FSChi cells. However, the exact lineage stage
from which granulocyte-macrophage progenitors can
develop may vary depending on conditions such as the
type of cytokine cocktail (Rieger et al., 2009). Therefore, we
cannotdefinitivelydetermine the stageof the initiallyplated
cells that gave rise mainly to macrophages in this assay.
To directly evaluate whether the colony-forming cells in
the CD45intLinSCA-1+FSChi fraction were progeny of
HSCs or independent of hematopoietic lineage cells, we
engrafted EGFP-HSCs into uncolored mice. The experi-
mental design, summarized in Figure 4D, was similar to
that described in a previous report (Hall et al., 2007). Threeors
Figure 4. HSCs Are the Only Contributor
to Postnatal Mouse Hematopoiesis
(A) Representative images on culture days 5
and 10. Each FACS-purified BM LinSCA-1+
fraction from Actin-EGFP mice was cocul-
tured with OP9 cells for the first 5 days (i.e.,
OP9 priming) and transferred to methylcel-
lulose for an additional 5 days (i.e., meth-
ylcellulose expansion). The threshold
between FSClo and FSChi was defined by
10 mm microspheres. Scale bar, 100 mm.
(B) The number of colony-forming units
(CFUs) from 103 cells of each LinSCA-1+
fraction. Data shown are mean ± SD of
four independent experiments. ND, not
detected.
(C) Proportion of colonies. From five inde-
pendent colony assays, 199 colonies derived
from CD45intLinSCA-1+FSChi cells and 250
colonies derived from CD45hiLinSCA-1+
FSChi cells were picked up, cytospun, and
stained with the May-Giemsa method to
determine the cell types included. CFU-M,
CFU-macrophage; CFU-G, CFU-granulocyte;
CFU-GM, CFU-granulocyte/macrophage;
CFU-Mix, CFU-erythroid and myeloid cells.
(D) Schematic of in vivo experiments.
(E) The number of CFUs from 103 cells of
each LinSCA-1+ fraction. Data shown here
are mean ± SD.
(F) Ten day progeny of CD45intLinSCA-1+
FSChi or CD45hiLinSCA-1+FSChi cells were
harvested with OP9 stromal cells and
analyzed by FACS. Live cells were gated and
tested for the expression of CD45 and GFP. A
total of 5 3 104 events were recorded. Data
were similar in three independent experi-
ments.
See also Figures S3 and S4.
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expressing HSCs, 98% of their peripheral blood cells (not
shown) and 96.8% of their BM granulocytes were GFP+
(Figure S4A). The frequencies of CD45, CD45int, and
CD45hi fractions within LinSCA-1+ gate in the chimeric
mice were comparable to those in age-adjusted nonirradi-
ated syngeneic mice (Figure S4B). We evaluated the fre-
quency of colony-forming cells in each fraction. As in
the experiments with mice that did not receive trans-
plants, a limited number of colony-forming cells were
detectable in the fraction of CD45intLinSCA-1+FSChi
and CD45hiLinSCA-1+FSChi cells (Figure 4E). AnalysisStem Cby fluorescent microscopy and flow cytometry confirmed
that all of the colonies derived from CD45intLinSCA-1+
FSChi cells (81/81) and CD45hiLinSCA-1+FSChi cells
(926/926) expressed GFP (Figure 4F). This indicates that
the CD45intLinSCA-1+FSChi cells that demonstrated he-
matopoietic potential originated from HSCs. Furthermore,
recipient CD45/int cells, including the previously re-
ported highly radiation-resistant VSELs (Ratajczak et al.,
2011), failed to respond to this critical myelosuppressive
condition and generate HSCs and/or their downstream
progenitors in vivo. In other words, HSCs, reported to
have little developmental plasticity (Wagers et al.,ell Reports j Vol. 1 j 198–208 j August 6, 2013 j ª2013 The Authors 203
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hematopoiesis.DISCUSSION
The existence of pluripotent cells after the preimplantation
blastocyst stage has not been demonstrated, except in the
case of germline stem cells. Therefore, VSELs and other
PSCs in postnatal mice must be independently verified to
change how we view events in embryogenesis and fetal
development. PSCs in postnatal humans, if they exist,
would have an extremely significant impact on society
because of their potential applications in research and
regenerative medicine. In fact, the discovery of VSELs has
already led to a commercial venture, Neostem, to bring
their potential to human therapies. One of its financial
backers, the Vatican, has announced in two symposia at
the Vatican that these cells represent an ethical alternative
to ESCs derived from humans (International Vatican Con-
ference, November 9–11, 2011 and April 11–13, 2013,
http://www.stemforlife.org/vatican-initiative).
In contrast to these optimistic findings, some groups
have recently reported on their failure to detect VSELs. To
accept a discovery as a scientific fact in the stem cell field,
we previously proposed that all of the following three
criteria are critical (Weissman, 2007): (1) the initial discov-
ery must be published in fully peer-reviewed journals; (2)
the experiment as published must be repeatable in many
independent laboratories; and (3) the phenomenon
described should be so robust that other experimental
methods must reveal it. And in the case of stem cells, the
regeneration derived from their transplantation should be
rapid, robust, and lifelong.
It is not infrequent that, although the initial findings are
peer-reviewed, subsequent attempts to independently
replicate the findings fail (Begley and Ellis, 2012).We there-
fore sought to employ a logical strategy to examine all the
cells within the CD45/intLinSCA-1+ population inmouse
BM, even going as far as to include dead cells and cell debris
in the analysis. Besides surfacemarkers, themain criteria for
the VSELs as defined by the original group are the following
two points: (1) very small in size (3–5 mm) and (2) pluripo-
tency. First, we tried to clarify whether this fraction con-
tains any viable cells of the reported small size. We found
that about 90% of all the events in this gate are indeed rela-
tively small and have much less DNA than that of diploid
cells according to SYTO16 staining measured on FACSAria
(Figure 1C). This suggests that these relatively very small
events are simply cell debris or fragments; subcellular parti-
cles, such as exosomes and blebs from dying cells, could be
included. Asmentioned above, it is unreliable to determine
absolute cell size by FSC intensity (Figure 2). Furthermore,204 Stem Cell Reports j Vol. 1 j 198–208 j August 6, 2013 j ª2013 The Authanymodifications such as fixation or cytospin have the po-
tential to affect the cell size. Therefore, we used an image
flow cytometer and directly measured the size of candidate
events without anymodification. This experiment revealed
that most of the SYTO16lo events lack the round shape of
cells and are jagged, suggestive of dead cells and/or cell
debris. SYTO16hi cells, both from CD45/intLinSCA-1+
and CD45hiLinSCA-1+ are not statistically different in
size and the majority are not small (<5 mm). However, we
were still able to detect an exceedingly rare population of
CD45/intLinSCA-1+SYTO16hi events, which we sought
to evaluate for pluripotency.
Since the original group reported that VSELs can survive
and differentiate to the hematopoietic lineage onOP9 cells,
we sought to evaluate these candidate VSELs by the same
assay, namely blood colony formation. When we cultured
all the SYTOX-Blue-positive cells in the CD45/int
LinSCA-1+ fraction (without size discrimination), no col-
ony formation was detected. This indicates logically that
SYTOX-Blue staining method can separate dead cells func-
tionally; there are no viable VSELs in the SYTOX-Blue-pos-
itive fraction. We were unable to detect any hematopoietic
cells among the SYTOX-Blue-negative CD45LinSCA-1+
cells—the ideal candidates for VSEL cells—under the
following additional conditions: (1) serial plating (previous
reports showed serial plating would recover cell growth;
Ratajczak et al., 2011); (2) using only the SYTO16hi cells ob-
tained from tenmice; (3) using cells fromH2K-BCL-2 trans-
genicmice (to improve viability by inhibiting programmed
cell death; Domen et al., 1998); or (4) using cells sorted on a
MoFlo machine (data not shown).
Sincewehave shownthat sizemaynotbea reliableparam-
eter in isolatingVSEL,we broadened our search bynot using
the size criteria while maintaining the immunophenotype
(CD45/intLinSCA-1+FSChi). Compared to CD45hiLin
SCA-1+FSChi cells, CD45intLinSCA-1+FSChi cells showed
much less hematopoietic differentiation potential, and it
never matched CD45hiLinSCA-1+FSChi cells, even after
serial plating, in contrast to the original group’s report (Fig-
ure 4B; data not shown; Ratajczak et al., 2011). However,
given our observation of some hematopoietic output from
the CD45intLinSCA-1+FSChi fraction, we sought to deter-
mine the developmental origin responsible: HSC or candi-
dateVSEL.All of thehematopoieticdifferentiationpotential
in the CD45intLinSCA-1+FSChi fraction were derived from
prospectively isolated and transplanted HSCs (Figure 4F),
suggesting that the only cells with hematopoietic differenti-
ation potential in the CD45intLinSCA-1+FSChi cells are
hematopoietic stem/progenitor cells.
Failure to detect hematopoietic lineage potential seri-
ously calls into question the existence of pluripotent
stem cells in CD45LinSCA-1+ cells. However, this finding
does not deny the existence of other multi- or oligopotentors
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ikawa et al. (2009) reported that CD45LinSCA-1+
platelet-derived growth factor receptor a+ cells in adult
mouse BM can give rise to mesenchymal stromal cells
both in vitro and in vivo.
At the time of our writing this report, a few independent
groups have replicated select aspects of VSEL: Bhartiya
et al., 2012 reported VSEL-derived TSCs existed inmamma-
lian ovary or in human BM and CB (Parte et al., 2011) and
Sovalat et al. (2011) claimed VSELs could be isolated from
human BM or granulocyte colony-stimulating factor
(G-CSF)-mobilized peripheral blood. However, all of these
other groups evaluated only the existence of VSEL by the
analysis of the cell size and immunophenotype without
evaluating the pluripotency criteria, as criticized by the
others in the field (Ivanovic, 2012). In fact, other recent re-
ports failed to detect the stem cell properties of mouse
(Szade et al., 2013) or human VSELs (Danova-Alt et al.,
2012). When only one or a few markers of cells rather
than the function of cells themselves are assayed, artifac-
tual or nonphysiological expression of single markers can
lead to the interpretation that a cell type rather than a
marker is being studied. The only assays acceptable for
functionally identifying stem cells are those that assess
(1) self-renewal; (2) differentiation to clonal progeny of
the cell types inferred from the name of the cell; and (3),
for adult tissue outcomes, robust and sustained regenera-
tion. The transfer of donormarkers to host cells could occur
by cell fusion and, theoretically, by exosome transfer, to the
extent that exosomes are shown to be physiological en-
tities and not cell culture artifacts.
We conclude that most CD45/intLinSCA-1+ cells in
mouse BM were not as small as previously reported. More-
over, even despite broadening our search to include larger
cells as candidates, we could not find a single instance of
CD45/intLinSCA-1+ cells that (1) expressed Oct4, (2)
proliferated to form spheres in cultures, or (3) demon-
strated the ability to generate cells of the hematopoietic
lineage—three functional aspects of pluripotency that
were previously reported. These results suggest the absence
of embryonic-like pluripotent cells in postnatal mouse BM.
Additional rigorous data would be needed to demon-
strate their existence both in humans and mouse before
clinical application, including the derivation of the same
repertoire of normal tissue cells currently demonstrated
with ESC and/or induced pluripotent stem cells.EXPERIMENTAL PROCEDURES
Mice
C57Bl/Ka-Thy1.2 Ly5.1 (B/Ka), C57Bl/Ka-Thy1.1 Ly5.1 (BA),
C57Bl/Ka-Thy1.1 Ly5.1-Tg (actin-EGFP), and C57Bl/Ka-Thy1.1
Ly5.1-Tg (pH2K-BCL-2) mouse strains were derived and main-Stem Ctained in our laboratory. The Oct4-EGFP transgenic strain (Tg
[Pou5f1-EGFP]2Mnn/J) was purchased from the Jackson Labora-
tory. The C57Bl/6J-W41/W41 strain was kindly provided by
Dr. Susan L. Hall, Loma Linda University. We used 4–12-week-old
female and male mice. All animal procedures were performed in
accordance with the International Animal Care and Use Commit-
tee and the Stanford University Administrative Panel on Labora-
tory Animal Care.
Cell Preparation and Staining
BM cells harvested from bilateral femurs and tibias with a flushing
methodwere treatedwith BD PharmLyse Buffer (BD PharMingen).
These cells were stained for 30minwith phycoerythrin (PE)-conju-
gated lineage antibodies (Lin), which consisted of anti-CD45R/
B220 (clone; RA3-6B2, final concentration; 4 mg/ml), anti-T cell re-
ceptor (TCR) b (H57-597, 4 mg/ml), anti-TCR gd (GL3, 4 mg/ml),
anti-Ly-6G/C (RB6-8C5, 8 mg/ml), anti-CD11b (M1/70, 4 mg/ml),
and anti-Ter119 (TER-119, 4 mg/ml); allophycocyanin-Cy7-conju-
gated anti-CD45 (30-F11, 8 mg/ml); and biotin-conjugated
anti-Ly6A/E (SCA-1) (E13-161.7, 10 mg/ml) followed by streptavi-
din-PE-Cy5 (1 mg/ml). All the antibodies were purchased from
BD. One micromolar SYTO16 (Life Technologies) was added to
evaluate DNA quantity.
Flow Cytometry
Sorting and analyses were performed on multilaser-equipped
FACSAria II and, where otherwise indicated, on a MoFlo cell sorter
or FlowSight image flow cytometer. Dead cells were distinguished
by adding 1 mM of SYTOX-Blue dead cell stain (Life Technologies).
To minimize contamination, a second round of sorting was per-
formed. The automatic cell deposition system was used for
single-cell assays. Data were analyzed with FlowJo software (Tree
Star) or IDEAS software (Amnis).
Isolation of HSCs and Candidate VSELs
By comparing the FSC of defined-size microspheres (Flow Cytom-
etry Size Calibration Kit, Life Technologies) and that of BM cells,
we evaluated relative cell size. The SCA-1 channel was separated
between negative and positive by the FMO method. We further
divided LinSCA-1+ cells into three subfractions according to the
CD45 expression level: the upper limit of the CD45 subpopula-
tion was defined by the FMO method; the CD45hi subpopulation
by the obvious positive peak; and the CD45int area as that between
CD45 and CD45hi. HSCs and candidate VSELs were expected to
reside in the CD45hiLinSCA-1+FSChi and CD45LinSCA-1+
(and/or CD45intLinSCA-1+) FSClo populations, respectively.
Sphere Formation Culture
AC2C12mousemyoblast-derived cell line wasmaintained in Dul-
becco’s modified Eagle’s medium (DMEM) containing 20% fetal
calf serum (FCS). For the sphere formation assays, freshly isolated
1 3 103 BM LinSCA-1+ cells from Actin-EGFP mice were: (1)
plated on the 1 3 105 C2C12 cells seeded the previous day on a
24 well plate and (2) cultured for 8 days in DMEM with 2% FCS.
Half of the culture media was changed every day. The grown
cells/clusters were trypsinized, harvested, passed through a
100 mm filter, and analyzed by FACSAria. The cells were alsoell Reports j Vol. 1 j 198–208 j August 6, 2013 j ª2013 The Authors 205
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Microsystems).
Nonfeeder Culture for Hematopoietic Differentiation
For liquid cultures, purified populations were suspended in 12 well
plates with the following medium: Iscove’s modified Dulbecco’s
medium (IMDM; Life Technologies) supplemented with 20%
FCS, antibiotics, 10 ng/ml of mouse (m) recombinant interleukin
3 (IL-3), 10 ng/ml mouse stem cell factor (SCF), and 10 ng/ml
mouse Flt3 ligand (R&D Systems). For clonogenic analyses of
CD45hiLinSCA-1+ (including HSCs) and CD45/intLinSCA-1+
(including VSELs) faction, cells were cultured 10 days in IMDM-
based methylcellulose medium (Methocult GF M3434; StemCell
Technologies), which contained FCS, bovine serum albumin,
2-mercaptoethanol, recombinant human (h) insulin and trans-
ferrin, as well as recombinant mSCF, mIL-3, hIL-6, and human
erythropoietin. All cultures were incubated in a humidified cham-
ber in 5% CO2. Colonies were scored and picked up for making
cytospin preparations to define cell components.
OP9 Coculture Assay
OP9 coculture was performed as previously reported (Ratajczak
et al., 2011). OP9 cells were maintained in a-MEM (MEMa Nucle-
osides Powder, Life Technologies) with 10% FCS. Freshly isolated
LinSCA-1+ cells (CD45, CD45int, or CD45hi) were plated on
OP9 cells in 12 well plates with a-MEM plus 20% FCS and cultured
for 5 days. Cultured cells were then trypsinized, centrifuged, and
replated in methylcellulose medium with OP9 cells. For serial pas-
sage, methylcellulose cultures were trypsinized, centrifuged, and
replated in new methylcellulose medium. Colonies were scored
and picked up to make cytospin preparations and stained by the
May-Giemsa method.
Purification of Long-Term HSCs and Transplantation
BM mononuclear cells from actin-EGFP mice were enriched for
c-kit+ cells by using anti-c-kit microbeads (Miltenyi Biotec) and
sorted for propidium iodideLin(CD3/CD4/CD8/Mac-1/Gr-1/
B220/CD19/Ter119)CD34CD150+Flk2c-kit+SCA-1+ long-term
HSCs. Eight-week-old W41/W41-recipient mice (Reith et al.,
1990), hematopoietic-deficient due to mutations in the W locus
encoding the c-kit gene, received 400 cGy total body irradiation fol-
lowed by intravenous injection of 100 sorted long-term HSCs via
the retro-orbital vein. Peripheral blood and BM cells were analyzed
by flow cytometry after transplantation to evaluate chimerism.
RNA Extraction and Real-Time RT-PCR
Prior to quantitative RT-PCR, 1 3 103 of each of the following cell
types were sorted by flow cytometry: CD45/intLinSCA-1+
SYTO16lo, CD45/intLinSCA-1+SYTO16hi, CD45hiLinSCA-1+
SYTO16hi, and SSEA-1hi ESCs. RNA extraction, reverse transcrip-
tion, and PCR amplification were performed by using CellsDirect
One-Step qRT-PCR Kit (Life Technologies) according to the manu-
facturer’s instructions. Gene-specific products were monitored by
the 7900HT Fast Real-Time PCR System (Life Technologies). Four
different design of primer pairs for Oct4 messenger RNA were
used: (1) designed by Niwa group (Toyooka et al., 2008), (2 and
3) designed by Ratajczak group (Kucia et al., 2006a; Liu et al.,206 Stem Cell Reports j Vol. 1 j 198–208 j August 6, 2013 j ª2013 The Auth2009), and (4) TaqMan probe set Mm.PT.51.7439100.g (Integrated
DNATechnologies). Primer sequences and amplicon sizes are listed
in Table S2.Statistical Analysis
The nonparametric Mann-Whitney test was applied to all compar-
isons of mean values after F-test evaluation of variances. All statis-
tical analyses were performed on Prism 5 software (GraphPad).SUPPLEMENTAL INFORMATION
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and can be found with this article online at http://dx.doi.org/10.
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